By Justin Petrone
Almac Diagnostics and the Queen's University of Belfast will use a £4.4 million ($7 million) grant to develop diagnostic, prognostic, and drug-specific tests for prostate, ovarian, and breast cancers, according to an Almac official.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.
Researchers report that what scents someone picks up can reflect their complement of immune genes.
The New York Times examines ethics and China's push to lead biomedical research.
At her blog, Sally Rockey dives into National Institutes of Health funding data.